We’re no strangers to firsts
TREMFYA® is the first medication of its kind to be approved by the Food and Drug Administration (FDA) in 2017 to treat adults with moderate to severe plaque psoriasis.
In July 2020, the FDA also approved TREMFYA® to treat adults with active psoriatic arthritis.
TREMFYA® Legacy
TREMFYA® has 14+ years of combined clinical research* and 6+ years on the market across indications.
*Based on a clinical trial of TREMFYA® initiated in 2009.
TREMFYA® results
In two clinical studies, at least 7 out of 10 patients saw at least 90% clearer skin at 16 weeks. Results may vary.
In one of those studies, nearly 7 out of 10 patients with 90% clearer skin at 16 weeks were still clearer at 5 years.
At 1 year and thereafter, patients and healthcare providers knew that TREMFYA® was being used.
This may have increased results. Results may vary.
TREMFYA® Safety Information
Ask your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.
TREMFYA® may cause serious side effects, including:
- Serious allergic reactions. Stop using TREMFYA® and get emergency medical help right away if you develop any of the following symptoms of a serious allergic reaction:
- fainting, dizziness, feeling lightheaded (low blood pressure)
- swelling of your face, eyelids, lips, mouth, tongue or throat
- trouble breathing or throat tightness
- chest tightness
- skin rash, hives
- itching
- fainting, dizziness, feeling lightheaded
(low blood pressure) - swelling of your face, eyelids, lips,
mouth, tongue or throat
- trouble breathing or throat tightness
- chest tightness
- skin rash, hives
- itching
- Infections. TREMFYA® is a medicine that may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with TREMFYA® and may treat you for TB before you begin treatment with TREMFYA® if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with TREMFYA®.
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
- fever, sweats, or chills
- cough
- shortness of breath
- blood in your phlegm (mucus)
- muscle aches
- warm, red, or painful skin or sores on your body different from your psoriasis
- weight loss
- diarrhea or stomach pain
- burning when you urinate or urinating more often than normal
- fever, sweats, or chills
- cough
- shortness of breath
- blood in your phlegm (mucus)
- muscle aches
- warm, red, or painful skin or
sores on your body different
from your psoriasis
- weight loss
- diarrhea or stomach pain
- burning when you urinate or
urinating more often than
normal
These are not all the possible side effects of TREMFYA®.
Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.
TREMFYA® may cause serious side effects including:
- See “What is the most important information I should know about TREMFYA®?”The most common side effects of TREMFYA® include:
- upper respiratory infections
- joint pain (arthralgia)
- fungal skin infections
- headache
- diarrhea
- herpes simplex infections
- injection site reactions
- stomach flu (gastroenteritis)
- bronchitis
These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How often will you need
to take TREMFYA®?
Day 1
1 injection on day 1
Week 4
1 injection 4 weeks later
Week 12 & beyond
1 injection every 8 weeks
Not Actual Size
You can take TREMFYA® by using either the One-Press patient-controlled self-injector or a prefilled syringe.
TREMFYA® is a single-dose 100 mg injection taken under the skin at weeks 0 and 4, and then every 8 weeks. That’s only 6 doses per year after 2 starter doses.
TREMFYA® is intended for use under the guidance and supervision of physicians. Patients may self-inject after proper training and physician approval.
Want to know more about dosing with TREMFYA®? Click here.
